Asthmatic, Children
Conditions
Keywords
Pulmonary rehabilitation, Asthma, Children, Teenager, Physical capacity
Brief summary
Asthma is one of the main chronic diseases in childhood and it is characterized by the inflammation of airways. Individuals with chronic lung disease are more susceptible to present reduction in exercise tolerance due to pulmonary limitations. The pulmonary rehabilitation may improve the physical capacity in asthmatic patients, as observed in other chronic lung diseases.
Detailed description
The asthmatic patient's clinical changes may impair their functional capacity and exercise tolerance. Thus, the treatment of these individuals should be extended to pulmonary rehabilitation. Randomized clinical trials have shown interesting results, whether in cardiopulmonary conditions, quality of life or in the number of crises, after applying pulmonary rehabilitation program in asthmatic children and adolescents. In a systematic review on physical training with asthmatic children and adolescents the authors concluded that physical activity should be recommended to this population, although some issues have not yet been clarified due to limitations in the clinical trial. The control of the disease has not been evaluated by specific questionnaires in any study. The assessment of inflammatory markers was rarely addressed and the same occurred in the quality of life after physical training. In addition, it is possible to question the intensity and frequency of training, factors that can significantly contribute to the intervention results. All these information let us know that is necessary a randomized control trial to answer questions about physical characteristics, quality of life, inflammatory markers, and muscles strength.
Interventions
Aerobic training
Chest physiotherapy: Flutter and muscle stretching
Sponsors
Study design
Eligibility
Inclusion criteria
* between six and 18 years old * asthma-diagnosed patients * under medical treatment and disease control
Exclusion criteria
* fail to carry out the protocol evaluations * interrupt the medical care and/or drug-based treatment * acute lung infection or other chronic lung diseases * other comorbidities (neuropathies, heart disease) * missing in more than 20% the rehabilitation protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physical capacity as measure by distance walked of shuttle walk test and oxygen consumption (VO2) | Physiscal capacity will be measured at the beginning and at the end of the protocol (after 8 weeks) | Modified shuttle test was conducted |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Muscle strength as measure by electromyography (EMG) | Muscles strenght will be measured at the begening and at the end of the protocol (after 8 weeks). | 1 maximal repetition was performed |
| Muscle endurance as measure by electromyography (EMG) | Muscles endurance will be measured at the begening and at the end of the protocol (after 8 weeks). | — |
| Quality of life measured by Pediatric questionnaire | Quesitionnaire will be measured at the begening and at the end of the protocol (after 8 weeks). | — |
| Inflammatory markers as measure by interleukines | Inflamatory markers will be measured at the begening and at the end of the protocol (after 8 weeks). | — |
Countries
Brazil